Skip to main content
Clinical Trials/NCT05941195
NCT05941195
Completed
Not Applicable

Investigation of the Effect of Cognitive Behavioral Approach-Based Psychoeducation on Addiction Profile, Self-efficacy and Addiction Course in Substance Use Disorder Randomized Controlled Experimental Study

Aydin Adnan Menderes University1 site in 1 country45 target enrollmentDecember 1, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Substance Use Disorders
Sponsor
Aydin Adnan Menderes University
Enrollment
45
Locations
1
Primary Endpoint
Addiction Outcome Assessment Index (AOAI)
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

This study, which was planned to examine the effects of cognitive behavioral approach-based psychoeducation on addiction profiles, self-efficacy levels and addiction courses in patients with substance use disorders, was carried out as a randomized controlled experimental study.

Detailed Description

It can be said that alcohol/substance nurses, by applying cognitive behavioral approach-based psychoeducation to patients with substance use disorders, can have a positive effect on reducing the severity of addiction, increasing their self-efficacy levels, and providing the care, education and counseling support that patients need. The aim of this study is to examine the effects of cognitive behavioral approach-based psychoeducation applied to patients with substance use disorder on addiction profiles, self-efficacy levels and addiction courses.

Registry
clinicaltrials.gov
Start Date
December 1, 2022
End Date
May 30, 2023
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Aydin Adnan Menderes University
Responsible Party
Principal Investigator
Principal Investigator

Cihan Kocairi

Research Assistant

Aydin Adnan Menderes University

Eligibility Criteria

Inclusion Criteria

  • To be diagnosed with "Substance Use Disorder" according to The Diagnostic and Statistical Manual of Mental Disorders-V,
  • To be over 18 years old,
  • Volunteering to participate in the research.

Exclusion Criteria

  • Other than Substance Use Disorder, chronic, requiring ongoing help and care the presence of a medical illness,
  • Being illiterate (the types of scales to be used must be self-report forms) because of).

Outcomes

Primary Outcomes

Addiction Outcome Assessment Index (AOAI)

Time Frame: The last measurement was made at the 5th week.

The Addiction Outcome Index (BASI) was developed to measure the treatment course and recovery level of addiction in all areas and to be used in follow-up. The score that can be obtained from the scale is between 0-32. A decrease of 3.5 points from the total score of the scale in clinical follow-up indicates a reliable change .

Addiction Profile Index (Bapi) Clinical Form

Time Frame: The last measurement was made at the 5th week.

Addiction Profile Index Clinical Form was created by adding 21 questions to the Addiction Profile Index developed in 2012 to measure the severity of addiction. It consists of 58 questions in total and has 11 sub-dimensions. It evaluates different dimensions of addictions of alcohol and substance users. Two of the six domains of the scale measure mental state, while the others measure some personal characteristics related to addiction.

Self-Efficacy Scale (SES)

Time Frame: The last measurement was made at the 5th week.

The scale was first developed in the English language in 1982 . It was adapted into Turkish in 1999 and follows the course of self-efficacy expectations that need to be changed in individual therapy during the therapy process. The Self-Efficacy Scale consists of 23 items and 4 sub-factors. A minimum of 23 and a maximum of 115 points can be obtained from the scale. A high total score from the scale indicates that the individual's self-efficacy perception is at a good level.

Study Sites (1)

Loading locations...

Similar Trials